Enzo Biochem Inc (NYSE:ENZ)

2.96
Delayed Data
As of 2:57pm ET
 -0.06 / -1.99%
Today’s Change
2.51
Today|||52-Week Range
6.13
-33.33%
Year-to-Date

Today’s Trading

Previous close3.02
Today’s open3.00
Day’s range2.92 - 3.01
Volume110,479
Average volume (3 months)204,430
Market cap$135.2M
Dividend yield--
Data as of 2:57pm ET, 03/06/2015

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+2.39%
P/E ratioNM
Price/Sales1.97
Price/Book3.62

Competitors

 Today’s
change
Today’s
% change
CDXSCodexis Inc-0.29-7.27%
ONTYOncothyreon Inc-0.04-2.80%
PRTOProteon Therapeutics...+0.02+0.19%
--Mologen AG-1.62-12.62%
Data as of 3:09pm ET, 03/06/2015

Financials

Next reporting dateMarch 10, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$95.9M
Annual profit (last year)-$10.0M
Net profit margin-10.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer, Director &
CAO
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account